<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03643380</url>
  </required_header>
  <id_info>
    <org_study_id>NSM-001</org_study_id>
    <nct_id>NCT03643380</nct_id>
  </id_info>
  <brief_title>Acute Study to Evaluate a Novel Implantable Midfield Powered Device in Humans With Urinary Incontinence</brief_title>
  <official_title>Acute Study to Evaluate a Novel Implantable Midfield Powered Device in Humans With Urinary Incontinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Neuspera Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Neuspera Medical, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A pre-market, prospective, non-randomized acute feasibility study for the treatment of
      patients with urinary incontinence (UI) as a consequence of urinary incontinence.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 17, 2017</start_date>
  <completion_date type="Actual">January 30, 2018</completion_date>
  <primary_completion_date type="Actual">November 15, 2017</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sacral Nerve Response measured by observed bellow response and big toe flexion</measure>
    <time_frame>Procedure</time_frame>
    <description>Stimulation of the S3 sacral nerve measured by observed bellows response and big toe flexion</description>
  </primary_outcome>
  <primary_outcome>
    <measure>AHLeveeS System placement in the S3 foramen assessed by fluoroscopy image</measure>
    <time_frame>Procedure</time_frame>
    <description>Confirm that the AHLeveeS System can be correctly placed and inserted in close proximity of the sacral nerve in the S3 foramina assessed by fluoroscopy image</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Overactive Bladder</condition>
  <arm_group>
    <arm_group_label>Investigational SNS device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AHLeveeS System</intervention_name>
    <description>AHLeveeS System for treatment of overactive bladder</description>
    <arm_group_label>Investigational SNS device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject was eligible for treatment and indication for the Medtronic InterStim system
             or InterStim II

          -  Subject wished to undergo an InterStim or InterStim II implant procedure after this
             acute clinical investigation

          -  Subject was in good health in the opinion of the investigator

          -  Subject was able to understand and voluntarily signed and dated the Ethics Committee
             approved informed consent form prior to initiation of any screening or study-specific
             procedures

          -  Subject was minimum of 18 years and maximum of 65 years of age

        Exclusion Criteria:

        - Subject had any of the contraindications for the InterStim system or InterStim II system
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gommert A. van Koeveringe</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maastricht University</name>
      <address>
        <city>Maastricht</city>
        <zip>6202 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>July 13, 2018</study_first_submitted>
  <study_first_submitted_qc>August 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 22, 2018</study_first_posted>
  <last_update_submitted>August 20, 2018</last_update_submitted>
  <last_update_submitted_qc>August 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Bladder, Overactive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

